Immedia Broadcasting plc
19 April 2004
19 April 2004
Immedia Broadcasting PLC
New Contract Win in Norway
The Board of Immedia, pioneers of live radio for retail, is pleased to announce
that it has signed a five year contract with Vitusapotek AS, one of the largest
pharmacy chains in Norway with 23.5% of the market.
The Vitusapotek idag radio station was launched on 13 April 2004. Broadcast in
Norwegian direct from Immedia's studios in Newbury, the radio station will
extend to 105 stores across Norway in May 2004.
Vitusapotek AS is a wholly owned subsidiary of the German company Celesio
(formerly known as GEHE) which also owns AAH Pharmaceuticals and LloydsPharmacy.
Commenting on this new contract, Bruno Brookes, Chief Executive of Immedia said:
'This contract represents an important stage in the growth of Immedia in
Northern Europe. Our clients' confidence in Immedia's ability to deliver foreign
language radio stations is an invaluable development.'
Enquiries
Immedia Broadcasting PLC Hudson Sandler
Bruno Brookes, Chief Executive Nick Lyon
Robert Parker, Finance Director Noemie de Andia
Tel: 01635 572 800 Sandrine Boussard
Tel: 020 7796 4133
Notes to Editors
Immedia Broadcasting PLC create live, tailored radio stations for major
retailers. Broadcast Live from studios in Newbury and operated via satellite
technology, encrypted signals are delivered to a decoder box in each of the
stores. These stations engage and educate staff and customers and have proved to
be a powerful and instantly flexible media channel to drive sales.
Existing stations are:
• 'Impulse Live', broadcast to newsagents and convenience stores including
Texaco and Londis;
• 'LloydsPharmacy Live', the largest community pharmacy operator with 1300
stores in the UK;
• 'Vitusapotek idag', broadcast in Norwegian to pharmacy retail stores in
Norway, and;
• 'Dixons Live' is currently broadcast to 50 of Dixons largest stores.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.